Amid complaints of 'severe' gastrointestinal side effects from patients, the FDA has issued an update about the weight-loss drug Ozempic.
that the FDA has decided to update the label for Ozempic to acknowledge one specific gastrointestinal disorder: Ileus. According to the news outlet, the labels of Mounjaro and another sister drug, Wegovy, already acknowledged reports of some users developing this condition—and now Ozempic's label has been updated to say the same.
"Ileus is the medical term for lack for movement somewhere in the intestines that leads to a buildup and potential blockage of food material," HRS explains , noting that this condition is commonly related to gastroparesis."An ileus can lead to an intestinal obstruction. This means no food material, gas, or liquids can get through.", the FDA does not directly blame Ozempic or Novo Nordisk for users developing ileus, however. Instead, the agency simply acknowledges that there have been some reports of people experiencing this gastrointestinal disorder following their use of the main medication used in Ozempic.
"The following adverse reactions have been reported during post-approval use of semaglutide, the active ingredient of Ozempic," the updated label states."Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA updates Ozempic label with potential blocked intestines side effect, also reported with Wegovy and MounjaroThe FDA stopped short of saying the potentially life-threatening condition was caused by the drugs, which have become popular for weight loss.
Read more »
FDA updates Ozempic label to acknowledge some users' reports of blocked intestinesThe U.S. Food and Drug Administration has updated the label of the diabetes drug Ozempic to acknowledge reports of blocked intestines in some people using the medication.
Read more »
FDA Adds Warning to Ozempic Label About Risk for Blocked IntestinesOzempic, a type 2 diabetes drug that has increasingly been used to help with weight loss, will now be labeled as having the potential to block intestines.
Read more »
The FDA Says Ozempic Might Block Your IntestinesOzempic, the uber-popular injectable diabetes drug, has had to update its potential side effect warnings to include intestinal blockage.
Read more »
Ozempic label updated after reports of blocked intestinesThe Food and Drug Administration updated the label of the diabetes drug Ozempic.
Read more »
Blocked Intestines Warning Added to Ozempic LabelOzempic, a Type 2 diabetes drug that has increasingly been used to help with weight loss, will now be labeled as having the potential to block intestines. The U.S. Food and Drug Administration recently made the label update for the drug made by Novo Nordisk, without directly...
Read more »